Pharmaceuticals in Australia

Pharmaceuticals in Australia

Summary

Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
• The Australian pharmaceuticals market registered revenues of $12.3 billion in 2023, representing a compound annual growth rate (CAGR) of 3.9% between 2018 and 2023.
• Australia captured a share of 3.1% of the Asia-Pacific pharmaceuticals market in 2023.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Australia
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Australia
• Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Australia pharmaceuticals market with five year forecasts

Reasons to Buy

• What was the size of the Australia pharmaceuticals market by value in 2023?
• What will be the size of the Australia pharmaceuticals market in 2028?
• What factors are affecting the strength of competition in the Australia pharmaceuticals market?
• How has the market performed over the last five years?
• What are the main segments that make up Australia's pharmaceuticals market?